chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Myalgia, Arthralgia, UricariaPruritus,  swollen lymph nodes near and around injection site, with standing and banding, pain to Right shoulder that continues months post vaccination ongoing presently.  Right Shoulder joint stiff with popping, and pain radiates up the neck and muscle  spasms ongoi  Narrative:  Employee Swollen lymph nodes near and around injection site, with  standing and banding, pain to Right shoulder that continues months post  vaccination ongoing presently. Right Shoulder joint stiff with popping, and pain  radiates up the neck and muscle spasms ongoing. and also radiates down the right  arm with a palpable cord harness where the vaccine was injected.
The day after my Shingles shot, I fainted twice. I thought it was an allergic reaction to the vaccine. - Called 911, after instructions from my Doctor, was admitted for 2 days. The diagnosis was orthostatic hypotension - not a reaction to the vaccine. I thought I should let you know there was NO allergic reaction
Significantly Dizzy; Confusion/disorientation; Confusion/disorientation; Headache; Nausea; Stomach ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198, expiration date: Jun2021) via an unspecified route of administration in the left arm on 10Mar2021 at 09:15 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, vitiligo, arthritis, migraines, hypothyroid, high cholesterol, reflux, IBC (Inflammatory breast cancer), penicillin allergy, sulfonamide allergy, shellfish allergy, and drug allergy (statins). Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included LEVOTHYROXINE; VERAPAMIL; FAMOTIDINE; VITAMIN D AND ASA, all for an unknown indication from an unknown date and unknown if ongoing. The patient previously took LEVOFLOXACIN, CODEINE, and NITROFURANTOIN, all for unknown indications, on unknown dates and experienced drug allergy. On 10Mar2021 at 10:00, the patient experienced significantly dizzy, confusion/disorientation, headache, nausea, stomach ache, and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events significantly dizzy, confusion/disorientation, headache, nausea, stomach ache, and fatigue was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Fever starting about 8 hours after injection, lasting about 24 hours. Abdominal pain about 8 hours after injection lasting 24 hours. Soreness in injection arm still present after almost 48 hours.
Arm pain; Dizzy; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), DIZZINESS (Dizzy), CHILLS (Chills) and PYREXIA (Fever) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included PROPRANOLOL, LOSARTAN and PANTOPRAZOLE for an unknown indication.    On 14-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jul-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), DIZZINESS (Dizzy), CHILLS (Chills) and PYREXIA (Fever). On 15-Jul-2021, DIZZINESS (Dizzy), CHILLS (Chills) and PYREXIA (Fever) had resolved. On 18-Jul-2021, PAIN IN EXTREMITY (Arm pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.   This case was linked to MOD-2021-317907, MOD-2021-317908 (Patient Link).
Shortness of breath, inability to talk, flushing, nausea, headache, tachycardia, vision blurred.
I got sick the next day BUT my main concern is the horrible bruising that started the next day where the shot was given. As the days passed it continued to get worse. I have pictures of my bruises. My 2nd dose is this Thursday 3/18 and I'm concerned  I shouldn't be getting it due to what has been reported recently in other countries with blood clotting Issues which has never been an issue for me in the past. Again I have pictures.
p/vax pt felt ill 24hr p/vax;generally didn't feel good, weak, tired laid in bed;no energy;felt like took 2-3mo to regain energy-bronchitis in april;
Information has been received from a physician concerning an 82 year old female who on 01-JUL-2007 at 13:30 was vaccinated SC in the left arm with a first dose of Zostavax (Oka/Merck).  There was no illness at the time of vaccination.  Immediately after vaccination, on 01-JUL-2007 at 13:30, the patient developed a rash, redness, swelling, itching, and burning at the injection site.  The patient was observed in the office and treatment was not required.  No diagnostic laboratory tests were performed.  The patient fully recovered on 02-JUL-2007.  A product quality complaint was not involved.  No further information is expected.
There was no seriousness criteria reported. In accordance with the manufacturer, jaundice was assessed as medically serious (OMIC). From initial information received on 9/27/04 from another manufacturer, initially reported by a health care professional, regarding an adverse event occurring in the USA, it was reported that a 31 year old female patient received her first dose of Hepatitis A vaccine - Havrix, on 9/1/04. The patient also received a dose of Typhim Vi and TD Adult vaccines. Information regarding lot number, route and sites of administration were not reported. Approximately six days post immunization, the patient experienced jaundice, fever, myalgia and fatigue. The outcome of these events were unresolved. The physician considered the events to possibly be related to the Havrix vaccination.
On 9/2 had her first Shingrix injection.  She had swelling and redness at the injection site for two weeks.  About three days after her injection she got her first herpes blisters on the lower left arm below the injection.  Since then she has had blisters break out on both her upper and lower right arm.  She has had three break outs of blisters so far, her most recent two days ago [upper right arm].  It looks like she will have scars from this. She said the blisters hurt and bleed a little before scabbing over but she has not taken anything for pain and doesn?t need any pain medication at this time.  We are using lotion on her skin because it is rough and shedding around the blisters.  We cover the blisters with band aids while they are bleeding.
Developed typical sciatic symptoms on R leg,   treated with IM steroid injection & oral dose pack   Patient able to walk but with pain
The patient was scheduled to receive a Pfizer bivalent dose and he received a monovalent dose. The vaccine given was also expired.
Left arm became tender to touch next AM after receiving shot.  No redness noted then or as time as progressed, but tenderness persists from injection site to approximately 6" further down arm.
NAUSEA, HEADACHE, STOMACH PAIN, AND FATIGUE START A WEEK AFTER INJECTION MOTHER STATE SHE TOOK CHILD FOR LAB WORK AND CT SCAN. MOTHER NOTIFY ME ON FRIDAY 11/07/2008 IN AM.  12/23/08 Reviewed PCP medical records from 6/08-11/08. FINAL DX: none provided Records reveal patient experienced intermittent nausea, epigastric abdominal pain, HA, fatigue, tiredness & hematochezia(NSAID induced) while out of country.  No weight loss.  Sleep disturbance w/pain.  Missed several days of school.  GI consult done.
After about 2 hrs started to feel nausea, numb of finger pain site of inj. was salty, blush and blue continued over weekend splotchy raised welt like spots in forearm and hand with blisters does not appear to be getting better pain has subsided. Primary MD has prescribed Famiciclovir feels shot may have brought out shingles.
Post 2nd dose pt c/o nausea, pt was sweaty and poor color. Pt was assessed by medics low pulse/bp.  Pt vomited x1 Pt transported to ED "not getting better".
Patient visited an urgent care facility approximately 3 weeks post-vaccination due to scattered flat rash on face and also requested pregnancy testing at that time.  Pregnancy test was positive.
After receiving the vaccine I was there for 45 mins after I received injection. I had tightness of chest, shortness of breath, dizziness, and light headed. They gave me a drink and candy to try to help while I was there. I was extremely dizzy and light headed. They were going to drive me home because I felt that bad. I didn't feel right for the rest of that day and a couple days after. I still dizziness and lightheadedness. I passed out from receiving the vaccine as well. I saw a PA and she ordered some test. I had a U/S Carotid Bilateral test done. I also had extended Holter monitor for 14 days and an echo cardiogram. I went for a follow up yesterday for a physical and I am being referred to an ENT and for some blood work because I am still having issues.
Rapid Rate 120-125 Atrial Flutter, for 2 1/2 weeks. October 12, ER. Amiodarone started. went home. October 19 admitted to hospital. Pneumonia COPD exaserbation, congestive heart failure, October 23,23. DCed with O2 at home. October 24, 23 does not require O2 & is doing well.
approx 5-10mins p/vax pt reported feeling drunk light headed & severe localized itching to lt arm-denies any throat tightness;lung sounds clear to auscultation;VS s/s of event 128/78 100 24 97.8 # 1510 150/88 84 20
This spontaneous report as received from a pharmacist refers to a 68 year old female patient. None drug reactions/allergies reported. On 04-NOV-2013 the patient was vaccinated with ZOSTAVAX (lot # J006156, expire date: 30-AUG-2014, 0.65 ml, subcutaneous). Concomitant therapies included pravastatin sodium, SPIRIVA, ESTRACE (vaginal cream) and PROAIR (unspecified). On 05-NOV-2013 the patient experienced bump toward the back of her mouth on her tongue. Eventually the same area of her mouth progressed to having 7 to 8 bumps. The patient visited her physician who told her to take BENADRYL. No lab test performed. It was reported that patient's symptoms were subsiding and she only had one bump at the time of report. The relatedness between ZOSTAVAX and the event was not reported. Additional information has been requested.
multiple small papules @ inject sites x 5D; tx DPH mom reports pt is scratching although has been giving pt DPH;
area of induration, warmth, erythema & swelling @ inj site & 10-15cm diameter surrounding area;
Normal pain at site; nause; diarrea; congestion; pain both ears; headache; dizziness; weakness; cough; joint and muscle aches; joint and muscle aches; chills; loss of appetite, taste and smell; loss of appetite, taste and smell; loss of appetite, taste and smell; fever; difficulty breathing; dehydration; throught swollen; This is a spontaneous report from a contactable Other Health Professional (patient). A 50-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in left arm on 30Dec2020 10:00 at single dose for COVID-19 immunization.  Medical history included covid from an unknown date and unknown if ongoing (Prior to vaccination, was the patient diagnosed with COVID-19: Yes). Known allergies: no. Other medical history: no.  Concomitant medication the patient received within 2 weeks of vaccination included bupropion, esomeprazole magnesium, lisinopril, magnesium citrate, magnesium oxide, riboflavin, tanacetum parthenium (MIGRELIEF), lisdexamfetamine mesilate (VYVANSE), Aller-itin.  If the patient received any other vaccines within 4 weeks prior to the COVID vaccine: No. Facility where the most recent COVID-19 vaccine was administered: Other. The patient experienced normal pain at site, nause, diarrea, congestion and pain both ears, headache dizziness, weakness. cough, joint and muscle aches, chills, loss of appetite, taste and smell, fever, difficulty breathing, dehydration, throught swollen, all on 31Dec2020 05:00 with outcome of recovering. The patient received treatment for the adverse event: cold medicine fluids paracetamol (TYLENOL) and sleep. Since the vaccination, has the patient been tested for COVID-19: No. AE was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Serious: No. Seriousness criteria-Results in death: No. Seriousness criteria-Life threatening: No. Seriousness criteria-Caused/prolonged hospitalization: No. Seriousness criteria-Disabling/Incapacitating: No. Seriousness criteria-Congenital anomaly/birth defect: No.    Information about Lot/Batch number has been requested.
Patient was admitted with bleeding into colsotomy bag after taking influenza shot 7 days earlier.He was admitted to ICU where he received FFP and blood transfusions.
The symptoms I had were mostly like a severe cold. I had a little bit of a cough. I never had a fever. The night before I went in for the test, I took some ZYRTEC that was helpful. It was really like a severe cold that lasted about 3 days. For about 3 weeks afterwards, I just had a little bit of congestion more than normal. I was given a Z-PAK to prevent a secondary infection. I was also suggested to continue ZYRTEC and to take PEPCID.
blood cancer; This is a spontaneous report from a Pfizer-sponsored Program. A contactable female consumer (patient) of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 01Mar2021, as the second single dose, for COVID-19 immunisation. Medical history included ongoing autoimmune disease and ongoing asthma. The first dose of BNT162B2 vaccine was administered on an unknown date. Concomitant medications were not provided. The patient had been recently diagnosed with cancer after she was vaccinated. She thought she has had this for a long time. She had blood cancer. Her doctor wanted her to get a booster. She knew there was none right now but she wanted to be in a clinical study and she said she also had an immunologist. She was on a steroid and will be starting chemo soon. Event outcome was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Mildly sore arm; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 26Apr2021 at 10:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date in 2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021, the patient experienced mildly sore arm. No therapeutic measures were taken as a result of the reported events. The event did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mildly sore arm was resolved on an unknown date in 2021.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Patient had vaccine, waited for 30 minutes for history of allergic reactions to insect bites. Patient left the site in an Uber and in transit took 50mg of Benadryl, after which started to develop mild swelling of the tongue and tingling in throat. She had the Uber driver bring her back to our location and informed us of the symptoms listed above, EMS was activated after which we administered 0.3mg of epinephrine and started an IV, and administered 20mg of famotidine. EMS arrived and transported the patient to the Emergency department.
Pt recvd 2nd dose of Hep B vax in MAY91 & devel arthralgia & myalgia recurred to a more severe degree;
Narrative:  95yo M only present to medical facility for covid vaccines and hearing aids. Pt received vaccines on 2/14/21 & 3/13/21. Pt died on 7/14/2021 with no cause of death noted. No medical history, no med list, no problem list, no vitals. No information to assess if death was vaccine related, but likely unrelated as last vaccine was given > 90 days of death & also considering pt's advanced age.
feeling very nauseous; weak; unable to breathe; muscles around my vital organs had swollen up so much; airways were blocked; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  An 18 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01Sep2021 15:00 (Batch/Lot number: unknown) at the age of 18 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. No known allergies. There were no concomitant medications. The following information was reported: NAUSEA (hospitalization) with onset 02Sep2021 06:00, outcome "recovered", described as "feeling very nauseous"; ASTHENIA (hospitalization) with onset 02Sep2021 06:00, outcome "recovered", described as "weak"; DYSPNOEA (hospitalization) with onset 02Sep2021, outcome "recovered", described as "unable to breathe"; MUSCLE SWELLING (hospitalization) with onset 02Sep2021, outcome "recovered", described as "muscles around my vital organs had swollen up so much"; OBSTRUCTIVE AIRWAYS DISORDER (hospitalization) with onset 02Sep2021, outcome "recovered", described as "airways were blocked". The patient was hospitalized for nausea, asthenia, dyspnoea, muscle swelling, obstructive airways disorder (hospitalization duration: 1 day(s)). The events "feeling very nauseous", "weak", "unable to breathe", "muscles around my vital organs had swollen up so much" and "airways were blocked" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: chest x-ray: (unspecified date) unknown results; sars-cov-2 test: (06Jan2022) negative, notes: Covid test type post vaccination: Nasal swab. Therapeutic measures were taken as a result of nausea, asthenia, dyspnoea, muscle swelling, obstructive airways disorder. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. Reported Event: I woke up about 15 hours after receiving the first dose of the vaccine, feeling very nauseous and weak. I went back to sleep, unable to attend school and then woke up about 2 hours later unable to breathe. I was taken to the ER where they determined that the muscles around my vital organs had swollen up so much that my airways were blocked and that it was a bad reaction to the vaccine. I was given oxygen and medication to relax my muscles and then instructed not to receive any further COVID vaccinations by various medical professionals. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events included: Oxygen, Medication.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a healthcare professional and described an adult subject of unspecified gender who did not respond to immunization with Engerix B for prophylaxis. On an unspecified date in 2006 the subject received an unspecified dose of Engerix B. The healthcare professional reported that the subject received the full vaccine series. On 25 October 2006, less than one year after vaccination with Engerix B, a hepatitis B surface antibody titer indicated that the subject had no response to the vaccine.
No known adverse effects; a 19 year old received a pediatric dose of VAQTA; This spontaneous report was received from a nurse prescriber via a company representative referring to a 19 year old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug allergies/reactions were not reported. On 24-SEP-2019, the patient received a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (strength, dose details, lot #, expiration date, route and anatomical location were not provided) for prophylaxis (product administered to patient of inappropriate age). No known adverse effects (no adverse event) were reported. No product quality complaint (PQC) was involved.
After each of 2 MMR booster, (2-27-12) and (4-13-12) - 7 days later had fever of 102 degrees, weakness, muscle aches, rash for several days.
shingles/red rash on her abdomen; painful and red rash on her abdomen/ postherpetic nervous system involvement; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 06-FEB-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered painful and red rash on her abdomen and was diagnosed with shingles and postherpetic nervous system involvement. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of both events was considered to be not recovered and causal relationship was assessed as related.   The lawyer considered both events to be disability.
Patient received her first dose of Moderna Covid vaccine on December 30, 2020, at 9:00 am. At 11;15 she started to experience palpitation and dizziness.  911 called and she has elevated blood pressure, she was sent to Medical Center.
After 1st dose on March 30, I started having dizziness and nausea on April 2. I have no history of dizziness or vertigo of any kind. Both the dizziness and nausea have  gotten worse each day sense and has not gone away as of today, April 6.
Patient did not report to us until 2 days later... but experienced itching and redness at the site of injection... warm skin and swelling.